To hear about similar clinical trials, please enter your email below
Trial Title:
the Quality of Life Assessment of Lung Cancer Patients in China
NCT ID:
NCT01914120
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Conditions: Keywords:
lung cancer
quality of life
FACT-L
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Summary:
The goal of this study is assess the quality of life of advanced non-small cell lung
cancer (NSCLC) patients who are undergoing first-line chemotherapy, analyze the current
status and tendency of quality of life (QOL). The method is to use the Functional
Assessment of Cancer Therapy-Lung (FACT-L) scales, assess the quality of life before the
chemotherapy, after 1st cycle of chemotherapy and after 2nd cycle. After 3 time-points,
investigators analyze all the subscales and constructs of FACT-L. The assumption is the
quality of life will be better after 2 cycle of chemotherapy.
Detailed description:
1. Lung cancer is the most deadly cancer in the world, 85% lung cancer are non-small
cell lung cancer (NSCLC). The quality of life of NSCLC patients become more and more
important, because of most NSCLC is incurable.
2. The recruitment will take place in 20 center all over the country and 500 patients
will enrolled.
Criteria for eligibility:
Study pop:
Advanced non-small cell lung cancer patients diagnosed by pathological or cytological
methods, and also have a imageological diagnosis within 6 weeks for clinical staging.
Clinical stage IIIB or IV. Chemo-naive patients: have never receive any kind of
anti-cancer chemotherapy.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- age: >18 and <75 years old
- pathological or cytological diagnosis confirmed advanced non-small cell lung cancer
- Eastern Cooperative Oncology Group Performance Status: 0-2
- have never receive any kind of anti-cancer chemotherapy
- agree to regularly assessment of quality of life
- sign the informed consent form
Exclusion Criteria:
- Currently attending any antitumor drug clinical trials
- Pregnancy or breast-feeding women
- Currently receiving anti-tumor chemotherapy, or received any antitumor chemotherapy
previously.
- not suitable to participate in this test
Gender:
All
Minimum age:
18 Years
Maximum age:
75 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Sun Yat-Sen University Cancer Center
Address:
City:
GuangZhou
Zip:
510030
Country:
China
Status:
Recruiting
Contact:
Last name:
YuXiang Ma
Phone:
8602087343786
Email:
mayx@sysucc.org.cn
Investigator:
Last name:
Li Zhang, professor
Email:
Principal Investigator
Start date:
November 2012
Completion date:
June 2017
Lead sponsor:
Agency:
Sun Yat-sen University
Agency class:
Other
Source:
Sun Yat-sen University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01914120
